ITE TL 2022-23 Flashcards
Blood:gas coefficient
ratio of gas dissolved in the blood and the alveoli at equilibrium
-larger -> higher solubility in blood -> slower onsent of action
second gas effect
rapid uptake of nitrous oxide into the blood -> second gas inc in conc due to loss of volume of nitrous oxide -> more rapid uptaek of 2nd inhaled anesthetic (more concentrated)
B:G coefficient Des, iso, Nitrous oxide, sevo
Des: 0.42
Nitrous: 0.46
Sevo: 0.65
Iso: 1.46
Vecuronium metabolism
metab by liver w/ byproduct w/ 80% potency -> metabolite (3-desacetyl-vercuronium) can build up in pts w/ renal insuff or liver failure
Vecuronium onset/duration
onset: 3-4 minutes, duration: 25-50 minutes
Pancuronium metab
Active metabolite -> build up in hepatic/renal failure -> prolongation of NMB
Cisatracurium metabolism
Hofmann elimination and ester hydrolysis (spontaneous degradation in plasma) -> inactive metabolite
Mivacurium metabolism
metabolized by pseudocholinesterases into inactive metabolites
Rocuronium metabolism
excreted unchanged by biliary and renal systems
-small amount metabolized by liver -> 17-OH roc -> minimal NMB activity
Potentiating NMB w/ inhalational gases, which the most?
DES!
Des > Sevo > Iso > nitrous oxide
Does that gas potentiate the NMB? Yes it DES!
Perip fluid management peds
Healthy peds pts elective surgery: 20-40 cc/kg over 2-4 hours LR,NS, plasmalyte
12 hrs post-op: 2-1.05 cc/kg/hr if not tolerating PO
When to use glucose containing solutions in peds
neonates, infants <6 months old, malnourished children, undergoing cardiac solution 1-2.5% dextrose
-be sure to monitor glucose!
Digoxin MOA
Glycoside -> positive ionotropic and negative dromotropic and chronotropic effects
-inc myocardial contractility, inc phase 4 depolarizations, and shortens action potential
-dec AV node conduction velocity, and prolongs refractory period of AV node
Digoxin toxicity symptoms
nausea, vomiting, diarrhea, abd pain
-vision changes yellow -> green, blurry vision,
=vent tachyarrythmias, and atrial tachycardia w/ AV block
-EKG: ST depressions, dec QT interval, inc PR interval, T wave inversions (normal w/ digoxin, not necessarily toxicity)
Digoxin toxicity inc risk
advanced age, worsening renal function, hypokalemia, low body weight, med noncompliance
beta-blocker toxicity
bradycardia, hypotension, hypoglycemia, hyperkalemia, wheezing,
severe: sz, deliriuum, and coma
PONV guidelines
-if any risk factor -> multimodal ppx
-RF: female, hx of PONV or motion sickness, postop opioids, non-smoker
-volatile anesthetics, nitrous, GA, long duration, young, gastric, gyn, or laparoscopic surgery
-1-2 RF: 2 interventions
-3-4 RF: 3-4 interventions
Jugular bulb venous O2 saturation monitoring
-put a catheter in retrograde and measure mixed venous sats at the jugular venous bulb
-measure of GLOBAL cerebral oxygenation, not local
(no change in stroke b/c local ischemia)
global cerebral oxygen supply and demand
supply: CBF, arterial oxygen content, and Hgb
demand: CMRO2
Cardiac myocyte action potential phases
phase 0: Depolarization
-VG Na channels open -> influx of + Na => membrane -90 to +20
phase 1: early rapid repolarization
-Na channel inactive, K ions exit cell -> dec in membrane potential
phase 2: plateau
-Ca active, Ca moves intracellularly, balancing out K leaving -> slows rate of decline in AP
phase 3: repolarization
-Ca inactive, K permeability inc -> AP decline
phase 4: resting potential
-normal cell permeability restored, Na-K-ATPase pumps K in and Na out
post-heart transplant heart
Denervated -> isolated from recipient nervous system
-only resp to direct myocardial adrenergic -> isoproterenol, epi, dob
-no resp to atropine, no resp to hypovolemia, no reflex for phenylephrine
-resting HR: 90-110
-accelerated rate of atherosclerotic disease
-no angina b/c denervated
tingling lateral surface of lower leg and dorsum of feet and toes, weakness w/ eversion of foot, what n?
Common peroneal nerve
-likely due to lithotomy position -> to dec minimize pressure at fibular head
Tramadol metabolism
PRO-DRUG
-metab by cytochrome p450 2D6 and 3A4
Tramadol MOA
After metabolism (pro-drug)
+ enantiomer: mu opiod agonist
- enantiomer: SNRI ( serotonin and NE reuptake inh)
Stages of liver transplant
preanhepatic, anheptic, and neohepatic
Preanhepatic
incision to cross-clamping of protal v, hepatic a, IVC or hepatic v
Anhepatic
cross clamping -> anastomosis are made and perfusion starts
Neohepatic
Unclamping of portal v when reperfusion starts -> hepatic a, biliary duct anastomosis, and abd closure
Changes during ischemia of liver
-lack of ATP -> can’t maintain ion gradients -> swelling
-alterations in Ca homeostasis
-hepatic cell death
-dec in cytoprotective substances
Reperfusion of liver possible issues
-build up of ischemic products (lactate, H+, K+), preservation solution released
-blood through graft -> release of microemobli
-hypoTN or arrhythmias
Postreperfusion syndrome
First 5 minutes after reperfusion -> systemic hypoTN and pulm HTN
-ischemia-reperfusion injury b/c low ATP and glycogen -> Na/K pump failure -> extracellular Na ions move into cells and cause swelling
-vascular permeability inc -> dec ATP and adenylate cyclase activity dec
Blood alteration if IgA def
washed RBCs
Acute hemolytic transfusion reaction
IgM antigen-antibody complex activating complement
Standard deviation percentages
SD 1 68%, 2 95%, 3 99%
CBF changes with hypothermia
for every 1 degree decrease, CMRO2 dec by 6%, proportional dec in CBF
PaCO2 and CBF
1 mm Hg in PaCO2, CBF changes by 3%
CBF and PaO2
constant for PaO2 >50-60
-inc dramatically when below 50
CBF and MAPs
CBF constant b/w 50-150
Specificity
TN/ (TN + FP)
“rules in” a disease
-confirmatory test
Sensitivity
TP/ (TP+FN)
-screening test
Which coronary cusp
Non-coronary cusp
-is always located next to the inter-atrial septum
-LCC is next to the pulm artery
-RCC is anterior most and faces RV
Which coags go down/no change in pregnancy?
XI, XIII: down
II, V: no change
all the rest procoag inc, anticoag decrease
Major RF for PONV
female sex, motion sickness, postop opioids, hx of PONV
Tetanus toxin MOA
prevents release of inhibitory neurotransmitters
-SNARE cleaved by tetanus prevents vesicle fusion and prevents release of GABA and glycine
Autonomic symptoms tetanus
Autonomic dysfunction: sweating, vasoconstriction, severe tachycardia w/ HTN may rapidly alternate w/ bradycardia and hypoTN
-abnormally high epi and NE -> exagg symp NS
-major cause of morbidity and mortality
Where tetanus acts
travels via retrograde axons from peripheral ro central neurons
-prevents GABA release in synaptic cleft b/w inhibitory interneurons and motor neurons
-enters brainstem to affect SNS
Botulinum toxin
only affects peripheral motor neurons, and prevents release of ACh into NMJ -> flaccid paralysis
Kartagener syndrome
primary ciliary dyskinesia
-can be associated w/ situs inversus, recurrent sinusitis, bronchiectasis
Bronchiectasis
-issue w/ mucociliary clearance -> recurrent lung infxn and inflammation -> localized and irreversible dilation -> dialted bronchial malacia -> airway collapse and impair mucus clearance
-w/ progression can have dec FEV1/FVC ratio
Bronchiectasis tx
prevention w/ aggressive antimicrobials
-inhaled corticosteroids may dec sputum production and inflammation
-chest PT
-if hemoptysis or recurrnt PNA, lung resection can be indicated
**treat like COPD, lots of PEEP
Nerve agents
Inhibit AChE
-SLUDGE Mi: Salivation, Lacrimation, Urination, Defecation, GI Upset, Emesis, Miosis
-arrhythmias, typically bradycardia but can be any
-ACh at nicotinic rec at NMJ -> fasciculations, twitching, fatigue, and flaccid paralysis
Why hypothermia in OR?
Anesthetic induced impaired thermoregulatory control, internal redistribution, red in head development, cold OR
Pattern of heat loss
initial rapid decrease then slow, linear reduction, then stabilization and plateau
Consequences of hypothermia
-coag impaired -> defect in platelet fxn
-dec drug metabolism
-***wound infxn inc (impairs immune fxn and dec wound O2 delivery)
-shivering -> hypoxia and ischemia
Prevention of hypothermia from redistribution
preop pre-warming -> inc preipheral temp before vasodilation
heat loss radiation
radiates heat to surrounding environment, heat transfered to from core to subq vessels -> lost to environment
**major loss type
heat loss convection
thin layer of air adjacent to skin acts as an insulator -> since air exchanged every 15 min in OR -> loss of insulator
heat loss conduction
transmission of boy heat through conducting medium (contact w/ mattress)
heat loss evaporation
liquid -> vapor lowering of kinetic energy
-when sterile prep solutions applied
RF for postop hospital admission
age over 65, long op times (>120 min), ASA III or IV, OSA, vascular dx
Thyrotoxicosis
Hypermet state from high thyroid hormone
-sym: nervousness, irritability, tremors, tachycardia, arrhythmias, fever, vomiting, diarrhea
Tx of thyrotoxicosis
PTU and Methimazole: inhibit production of thyroid hormone
-PTU: prevents peripheral conversion of T4 to T3
-can be used as a therapy or bridge to tx w/ surgery or radioactive I
radioactive iodine
used to destroy thyroid gland
-SE: inc hyperthyroid sym the first few days b/c destroy gland -> hormone release
-pre treat w/ methimazole or propanolol
-CI: breast-feeding, pregnancy
Complications w/ periop hyperglycemia
-immunosuppression -> dec WBC fxn
-inc infections
-stim of sympatho-adrenergic activity
-osmotic diuresis
-red skin graft success
-inc catabolism in burn pts
-delayed wound healing
-delayed gastric emptying
-exacerbationo f brain, SC, and renal damage by ischemia
-increased mortality
-risk of postop cognitive dysfxn following CABG
What’s in cryoprecipitate
vWF, fibrinogen, fibronectin, factor VIII, and factor XIII
Indications for cryo
-microvascular bleedingw/ low fibrinogen (ex DIC)
-bleeding due to uremiathat is unresponsive to DDAVP
-factor XIII def
-ppx before surgery or tx of bleeding w/ congenital dysfirinogen, VW Dx, Hemophilia A (if factor concentrates unavailable)
-use in firbin sealant production
SE of high dose oxytocin
-Oxytocin mimics vasopressin -> dec urine excertion
-volume overload sensed by atria -> ANP -> natriuresis -> hypoNa
-hypoTN -> N/V
Normal fetal pH
7.32 to 7.38
Normal pregnant mother pH
7.43 -> chronic resp alk
Fetal ion trapping
low fetal pH
-crosses placenta in un-ionized form, accepts aH ion in more acidic environment -> drug accumulates and then b/c ionized can’t cross back
why does lidocaine accumulate w/ ion trapping
pKa is 7.8 -> once in pH lower than 7.8 it accepts a H ion
Determines if drugs cross placenta
-Size: drugs <500 Da cross easily, >1000 Da (heparin, protamine, insulin) don’t cross
-Degree of lipid solubility, ionized (succ, NDMR) don’t cross, lipophilic (fent) do
-Protein binding: highly protein bound less likely to cross
-Maternal drug conc: higher conc morel ikely to cross
Drugs that do NOT cross Placenta
He Is Going Nowhere Soon
Heparin
Insulin
Glycopyrrolate
NDMR
Succinylcholine
Reversal of MR in pregnant pts
Neo and atropine
-Neo crosses, glyo doesn’t -> fetal bradycardia
Lowest blood:gas coefficient
Des < N2O < Sevo < Iso
blood: gas partition coefficient
ratio of the concentration of inhaled anesthetics in blood to conc in alveoli at equilibrium
-Lower = faster onset
Why is nitrous faster than Des
Des has a lower blood: gas coefficient, but “concentration effect” -> nitrous has a bigger concentration
B:G coefficients
Des 0.42
nitrous 0.46
sevo 0.65
iso 1.46
Secondary HSV active gental wounds what to do
C/s
-no invasive fetal monitoring
Conn Syndrome: cause and tx
Primary hyperaldosteronism: excess secretion of aldosterone from adrenal adenoma
tx: Spironolactone, anti-HTN, supplemental K
Sym of primary hyperaldo
fatigue, m cramps, weakness, polyuria, HA
(from HTN and hypoK from excess aldo)
Midodrine MOA
alpha 1 rec agonist
Octreotide
Somatostatin analogue
-used in acromegaly (supp GH production)
Congenital Diaphragmatic Hernia
-L side more common, more common in females
-Triad: dyspnea, cyanosis, and dextrocardia
-assoc w/ congenital heart dx and intestinal malrotations
TEG parts
R time: clot initation
K and alpha angle: clot kinetics
MA: clot strength
Ly30: fibrinolysis, clot stability, breakdown
TEG R
t=0 to initial clot formation
-dpt on clotting factors
-tx: FFP
TEG K and alpha angle
strength of clot formation, alpha measures speed of clot formation
-dpt on fibrinogen
-tx: cryoprecipitate
TEG MA
strength of clot, and maximum width of TEG
-dpt on plt number, function, and fibrin cross linking
-tx: plts
Desmopressin uses
When fxnl issue w/ plts (dec MA on TEG)
-causes release of endothelial cell stoes of factor VII and vWF, inc plt glycoprotein expression
-used for uremic bleeding or vWD
Normal TEG values
Rule of 6’s
R time: 6 minutes
alpha angle: 60 degrees
MA: 60mm
Ly30 6%
location of landmark interscalene block
behind the lateral border of SCM at level of cricoid cartilage
Coverage for interscalene block
Ventral rami of C5-C7, and supraclav (C1-3)
-100% block ipsilateral phrenic nerve -> hemidiaphgramatic paralysis
-covers shoulder and proximal upper extremity -> ulnar spared so no forearm or hand
Interscalene block landmark technique w/ n stim
at level of cricoid cartilage, posterolateral to SCM, in interscalene groove, insert needle, move caudad -> until movement of deltoid, triceps, biceps or pectoralis gets a response
-make sure stim at 0.4 mA, if stim at < 0.2 mA intraneural, pull back
hyperparathyroid and NMB
thought is hyperparathyroid -> inc Ca and inc in ACh rec -> hyposens to NDMR but resp is variable and unpredictable
Gold standard for core temp
pulmonary artery via pulm artery catheter
Acceptable alternatives for core temp
nasopharynx, distal esophagus, tympanic membrane
Pregnancy factor level changes
INCREASE: factor I (fibrniogen), factor VII, smaller inc in others
DECEASE: anticoag: antithrombin III, and protein S
Normal coags in pregnancy labs
20% decreasein PT, PTT
-dilutional effect on plts dec
Gestational thrombocytopenia
plts < 150k
Which factors procoag DEC in pregancy
XI, XIII
Pregnancy TEG
dec R time, K, alpha angle, MA
hypercoag
TX for congenital long QT syndrme
BB: propranolol, nadolol
QT prolongation leads to
syncope, cardiogenic sz, MI, sudden cardiac death -> all from polymorphic tachyarrhthmia, torsades
Tx for QT prolongation causing torasades
unsynchronized cardioversion and 2g Mg sulfate
Myasthenia Gravis risk for postop ventilation
-Diagnosis > 6 years
-Vital capacity < 2.9 L
-Daily dose > 750mg
-chronic respiratory illness
secondary:
-EBL >1L
-BMI >28
-advanced stage of MG
-hx of MG crisis
-Anti-ACh titer > 100 nmol/mL
-pronounced decremtanl resp (18-20%) on low freq repetitive n stim
Myasthenia gravis and NMB
-very sensitive to NDNMB
-resistant to succ
Change for CBF and temp
6-7% change by 1degree C in temp
Hypothermia body changes
-dec in speed of chemical and enzyme rxns -> less metabolism
-peripheral vasoconstrictin -> inc SVR and inc BP
-if <32 cardiac conduction slows -> bradycardia
-diuresis -> contraction of blood volume -> inc Hct and viscosity
-leukocyte and plt fxn dec
-dec in insulin sensitivity and secretion -> hyperglycemia
-arterial partial P of O2 and CO2 dec b/c soluble in blood
inhalational agents and fetus
cross placenta esaily b/c higher lipid solubility and low molecular weight
Possible SE of inc intra abbd pressure from repairing gastroschisis
-abd compartment syndrome
-compress IVC -> hypoTN
-compress liver and kidney -> altered drug metabolism
-prevent diaphragm excusion -> red lung compliance -> inc peak and plateau pressures
-inc in ICP (inc in intrathoracic pressure reduces cerebral venous return)
Inc in peak pressue w/o inc plateua pressure
inc in airway resistance -> bronchospasm, ETT obstruction, mucous plugging, kink in circuit, retrained secretion
Inc in peak and plateau pressure
PTX, pulm edema, ARDS, PNA
Labetalol half life, effect on BP
1/2 life: 6 hours
effect on BP: 16-18 hours
Labetalol MOA
antagonism to alpha 1: arteriolar vasodilation
antag to beta 1: dec HR and dec contracility
antag to beta 2: arteriolar vasodilation
Labetalol metabolism
hepatic glucuronide conjugation w/ excretion via urine and feces
Esmolol half life
9 minutes
Esmolol metabolism
metabolized by RBC estereases -> short 1/2 life
-useful to tx acute tachycardia => dose dpt response
-used for DL to attenuate symp response
Abx that do NOT affect NMB
PCN and cephalosporins
Abx that inc NMB
aminoglycosides (Gentamycin), polymixins, lincosamides: clindamycin
-gluoroquinolones and tetracyclines
Prolong NMB
-inh gas: des most
-Lithium (activates K inhibit ACh release)
-Mg (block Ca)
-CCB
-acute antepileptics
Chronic antiepileptic drugs and NMB
inc conc of serum glycoproeins and postynatpic nAChR -> more rapid clearance and shorter duration of action
What’s blocked in adductor canal block
vastus medialis is the ONLY muscle, remaining sensory block (saphenous on)
boundaries of adductor canal
vastus medialis laterally, sarterius anteriorly (roof), adductor longus (superior) or magnus (inferior)
Fascia iliaca block
Blocks femoral and LFCN
-large volume
Zero-order kinetics
Will eliminate a constant amount of drug per unit time, regardless of plasma conc
-ethanol, cisplatin, phenytoin, high dose salicylates
First order kinetics
eliminate a constant fraction of drug per unit time (decreases exponentially)
-higher conc, faster clearance
LFCN
L2-L3 n roots, sensory innervation to anterolateral aspect of thigh
-blocked for surgeries w/ femoral neck or skin grafting on thigh, or muscle biopsies of lateral thigh
LFCN location
emerges from lateral border of psoas, crosses iliacus m toward ASIS, behind/through inguinal ligament, in front of sartorius
LFCN block
ASIS, -1 cm medical and 1-2 distal, advanced until pierces fascia lata
Meraglia paresthetica
d/o LFCN -> pain, parethesia, hypesthesia in anterolateral thigh assoc w/ n compression
-LFCN n block is diagnostic
Intravascular injxn of caudal anesthesia symp
inc in 25% or more in T-wave amplitude
inc HR and BP (T waves more reliable b/c not guaranteed when under GA)
Layers to femoral block
Skin, subq, fascia lata, and fascia iliacus
Temp and CMRO2
each degree C < 37, CMRO2 dec by 6-7%
gold standard of cerebral temp
jugular bulb venous temp
Oxygenator arteial outlet temp
measures temp of the arterial blood leaving CPB circuit and entering body via aortic cannula
NG and dec myocaridal demand
preferentially dilates Venules -> dec preload
v > a
NG onset and 1/2 life
onset: 1-3 minutes, 1/2 life 2-3 minutes
metab by liver
NG MOA
smooth m: activates guanylyl cyclase to inc cGMP -> inh Ca into cells -> smooth m relaxation
Artery of Adamkiewicz supplies
anterior 2/3 of SC T9-T12 -> loss of motor fxn of lower extermities, loss of pain and temp 1 level below lesion, sexual dysfxn, urinary and fecal incont
-proprioception and vibration intact (posterior a)
spinal n
anterior: motor, posterior: sensory root
Anatomical landmarks for dermatomes
Dermatomes
surgery post DES
elective is 6 months
surgery post bare metal stent
30 days
anatomy near stellate ganglgion
carotid a anterior to at level of C6
anterior to neck of the first rib and C7 transverse processes
lateral: scalene muscles
posterolateral: vertebral arteries
Obesity changes on lung volumes
Dec compliance -> shallow breaths, inc WOB, and limited max VC
-dec FRC (dec ERV), dec TV, dec TLC
-RV unaffected
-FEV1 and FVC slightly decreased, ratio preserved or slightly inc
-nc O2 consumption and CO2 production due to inc adipose tissue
NG MOA
enters endothelial cells from the bloodstream and are converted to nitric oxide intracellularly -> smooth m relaxation (incl uterine smooth m)
-nitric oxide -> cGMP -> sequesters intracellular Ca
SE of NG
tachycardia, hypoTN, flushing, and HA